腹腔大动脉瘤进展:临床前和临床数据的综述
Nadjib Schahab1, Sara Würbel2, Lucas Busch3
1Heart Center Bonn, Department of Medicine II, University Hospital Bonn, Bonn, Germany. Nadjib.schahab@ukbonn.de.
概括
腹腔大动脉动脉瘤 (AAA) 的进展复杂且不太了解,阻碍了有效的治疗. 进一步的研究对于开发向疗法和改善这种危险的血管疾病患者的治疗结果至关重要.
科学领域:
- 血管生物学和医学 血管生物学和医学
- 心血管研究研究心血管研究
- 生物医学工程 生物医学工程
背景情况:
- 腹腔大动脉瘤 (AAA) 是一种危及生命的血管疾病,死亡率高,尽管目前的干预措施.
- AAA的进展涉及诸如炎症,矩阵降解和重塑等复杂的机制,这些机制尚未完全阐明.
- 目前的理解限制了针对性治疗和AAA破裂的准确风险分层.
研究的目的:
- 审查和巩固当前关于腹腔大动脉瘤 (AAA) 病理生理学,流行病学和治疗挑战的知识.
- 突出综合性研究的必要性,以澄清AAA进展机制.
- 讨论潜在的治疗策略和风险评估改进.
主要方法:
- 文献综述巩固了关于AAA的当前知识.
- 对推动AAA进展的生物机制的分析 (炎症,ECM降解等). ) 的情况.
- 评估当前和新兴的治疗策略和风险评估模型.
主要成果:
- AAA的进展是由内皮功能障碍,慢性炎症,细胞外基质降解和蛋白质分解活性驱动的.
- 吸烟和高血压等危险因素加剧了血管壁的压力和动脉瘤的生长.
- 目前的治疗方法有局限性,有希望的临床前策略包括准炎症细胞和使用纳米粒子药物输送.
结论:
- 更深入地了解AAA病理生理学对于开发有效的个性化治疗是必不可少的.
- 需要综合性研究,结合生物力学,先进的成像和分子途径.
- 新型的治疗点和药物输送系统显示出缓解AAA进展和改善患者结果的前景.
相关概念视频
Aneurysm II: Clinical Manifestations and Diagnostic Studies
258
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
258
Aneurysm III: Interprofessional Care
249
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
249
Aneurysm I: Introduction
336
An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...
336
Aortic Regurgitation I: Introduction
444
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
444
Atherosclerosis I: Introduction
853
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
853
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
450
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
450


